These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 38946682)

  • 1. GSK3: A potential target and pending issues for treatment of Alzheimer's disease.
    Zhao J; Wei M; Guo M; Wang M; Niu H; Xu T; Zhou Y
    CNS Neurosci Ther; 2024 Jul; 30(7):e14818. PubMed ID: 38946682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
    Ly PT; Wu Y; Zou H; Wang R; Zhou W; Kinoshita A; Zhang M; Yang Y; Cai F; Woodgett J; Song W
    J Clin Invest; 2013 Jan; 123(1):224-35. PubMed ID: 23202730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.
    Gao C; Hölscher C; Liu Y; Li L
    Rev Neurosci; 2011 Dec; 23(1):1-11. PubMed ID: 22718609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3 in Alzheimer's disease: mind the isoforms.
    Ma T
    J Alzheimers Dis; 2014; 39(4):707-10. PubMed ID: 24254703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent roles of GSK3 and CDK5 in APP processing.
    Ryder J; Su Y; Liu F; Li B; Zhou Y; Ni B
    Biochem Biophys Res Commun; 2003 Dec; 312(4):922-9. PubMed ID: 14651959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
    Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E
    J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
    Wadhwa P; Jain P; Jadhav HR
    Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK3 and tau: two convergence points in Alzheimer's disease.
    Hernandez F; Lucas JJ; Avila J
    J Alzheimers Dis; 2013; 33 Suppl 1():S141-4. PubMed ID: 22710914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3: a possible link between beta amyloid peptide and tau protein.
    Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
    Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease.
    Qu L; Li S; Ji L; Luo S; Ding M; Yin F; Wang C; Luo H; Lu D; Liu X; Peng W; Kong L; Wang X
    Eur J Med Chem; 2021 Dec; 226():113889. PubMed ID: 34649182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 signaling in Alzheimer's disease.
    Lauretti E; Dincer O; Praticò D
    Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118664. PubMed ID: 32006534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
    Cai Z; Zhao Y; Zhao B
    Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein.
    Parr C; Carzaniga R; Gentleman SM; Van Leuven F; Walter J; Sastre M
    Mol Cell Biol; 2012 Nov; 32(21):4410-8. PubMed ID: 22927642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.
    Hu S; Begum AN; Jones MR; Oh MS; Beech WK; Beech BH; Yang F; Chen P; Ubeda OJ; Kim PC; Davies P; Ma Q; Cole GM; Frautschy SA
    Neurobiol Dis; 2009 Feb; 33(2):193-206. PubMed ID: 19038340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β (GSK3β) activity: novel mechanism for Pin1 to protect against Alzheimer disease.
    Ma SL; Pastorino L; Zhou XZ; Lu KP
    J Biol Chem; 2012 Mar; 287(10):6969-73. PubMed ID: 22184106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.